Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization

Conditions

• Cancer-related Venous Thromboembolism

Eligibility Criteria

Sex

ALL

Age

18 Years - N/A

Healthy Volunteers

Not accepted

Interventions

• Questionnaires — BEHAVIORAL
  Questionnaires completed at the time participant joins this study and then about 30 days, 3 months, 6 months, and 12 months after that. Questionnaires will be about quality of life and experiences with treatment for venous thromboembolism (VTE). It should take less than 10 minutes to complete the questionnaires each time.

Study Details

The goal of this research study is to learn about the quality of life, experiences with treatment, and healthcare costs of patients who are receiving long-term treatment for venous thromboembolism (VTE) that is related to cancer. This is an investigational study. Up to 260 participants will be enrolled in this multicenter study. Up to 170 will take part in MD Anderson.

Key Dates

Start date

Jan 12, 2018

Status verified

May 2026

Primary completion

Dec 31, 2026

Completion

Dec 31, 2026

Study Design

Enrollment

260 participants (estimated)

Arms

• Arm: Questionnaires
  Questionnaires completed at the time participant joins this study and then about 30 days, 3 months, 6 months, and 12 months after that. Questionnaires will be about quality of life and experiences with treatment for venous thromboembolism (VTE).

Primary Outcome Measure

Self-Reported Adherence to Anticoagulation [ Time Frame: Baseline up to 6 months ]

Central Contacts

• Cristhiam M. Rojas Hernandez, MD
  713-563-3070
  [email protected]

Locations (1)

Find similar trials in Houston, TX